Evolution of the Average Target: Epiroc AB

Evolution of the Target Price: Epiroc AB

Changes in Analyst Recommendations: Epiroc AB

f.wO11g7IQucW5EP_xLMoiyNCaJMZReUi6Cl7xw3NLyww.lrkq1NpT1oL_ZIa_Z_8av4atEos2GxnVZxerlzEUmFuS2wfU_3jRge1Ezw~dce2c1cdedf838e32797e35b08ec92df
12-09 BNP Paribas Exane Upgrades Epiroc to Outperform (Neutral), Price Target Set at 240 Kronor - BN FW
12-05 Volvo receives a buy recommendation on BofA's engineering list for 2026 - Epiroc and Assa Abloy receive an underperform recommendation. FW
12-04 JP Morgan Raises Epiroc Target Price to 210 Kronor (205), Reiterates Neutral Rating - BN FW
12-04 Barclays Raises Epiroc Target Price to 250 Kronor, Reiterates Overweight - BN FW
12-01 Pareto Makes Major Overhaul to Swedish Model Portfolio (Update) FW
12-01 Pareto Makes Major Changes to Swedish Model Portfolio FW
11-11 Handelsbanken Sees Industrial Sector on the Rise - Highlights Seven Buy-Worthy Companies FW
11-11 Goldman Sachs Lowers Price Target for Epiroc to SEK 198 (205), Reiterates Neutral Rating - BN FW
10-31 Morgan Stanley Lowers Price Target for Epiroc to 200 Kronor, Maintains Equal-Weight Rating - BN FW
10-30 Danske Bank Downgrades Epiroc to Hold (Buy), Sets Target Price at 225 Kronor - BN FW
10-30 Deutsche Bank Raises Epiroc Target Price to 199 Kronor, Reiterates Hold Recommendation FW
10-30 JP Morgan lowers target price for Epiroc to SEK 205 (210), reiterates neutral rating - BN FW
10-30 Barclays Lowers Price Target for Epiroc to 245 Kronor (250), Reiterates Overweight - BN FW
10-27 Epiroc is expected to report SEK 3,010 million in adjusted operating income - Factset FW
10-09 Morgan Stanley Raises Epiroc Target Price to SEK 202 (198), Maintains Equal Weight - BN FW
10-08 Stockholm Bullets - ABB and Xspray Pharma in the spotlight FW
10-08 JP Morgan Raises Target Price for Epiroc to 210 Kronor (200), Maintains Neutral Rating - BN FW
10-07 Citigroup Raises Price Target for Epiroc to 240 Kronor, Reiterates Buy - BN FW
10-07 SEB raises target price for Epiroc to SEK 238 (217), reiterates buy recommendation - BN FW
10-06 BNP Paribas Exane Raises Epiroc Target Price to SEK 215 (210), Maintains Neutral Rating - BN FW
10-06 Pareto Upgrades Epiroc to Buy as Stock Lags Behind Competitors FW
10-06 Pareto Securities raises Epiroc to buy (hold), target price SEK 230 (220) FW
10-02 Industrial Cycle Shows Signs of Bottoming Out, Focus Shifts to Quality Stocks - Handelsbanken FW
09-30 Deutsche Bank Lowers Price Target for Epiroc to 196 Kronor, Reiterates Hold FW
09-30 Epiroc Replaces Sandvik as Sector Favorite at Handelsbanken FW
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-1.14%
-0.78%
-4.56%
+13.23%
+2.04%
+63.49%
+3.91%
+2.26%
-3.19%
+3.89%
Average +7.91%
Weighted average by Cap. +5.76%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
213.50SEK
Average target price
211.06SEK
Spread / Average Target
-1.14%
High Price Target
250.00SEK
Spread / Highest target
+17.10%
Low Price Target
175.00SEK
Spread / Lowest Target
-18.03%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Nordea Bank
Oxcap Analytics
Morgan Stanley
Bernstein
Citigroup
Barclays
Pareto Securities
JPMorgan
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
213.50SEK
Average target price
211.06SEK
Spread / Average Target
-1.14%
Consensus

Quarterly revenue - Rate of surprise